Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 27.26 is 64% above its 5-year average of 16.64, near the high end of its 5-year range (7.52–28.93).
As of the fiscal period ended Tuesday, June 30, 2026. 71.67% above its 12-month average of 15.88.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 27.26.
QUICK RATIO (ACID-TEST)
27.26
QUICK RATIO (ACID-TEST) AVG TTM
15.88
QUICK RATIO (ACID-TEST) AVG 3Y
12.44
QUICK RATIO (ACID-TEST) AVG 5Y
16.64
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+71.67%
CURRENT VS 3Y AVG
+119.23%
CURRENT VS 5Y AVG
+63.84%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
+712.66%
vs the sector median at left
Rallybio Corporation
Market Cap
$90.64M
Quick Ratio (Acid-Test)
27.26
TTM Avg
15.88
3Y Avg
12.44
5Y Avg
16.64
Market Cap
$90.37M
Quick Ratio (Acid-Test)
3.47
TTM Avg
4.19
3Y Avg
5.60
5Y Avg
16.48
Market Cap
$90.20M
Quick Ratio (Acid-Test)
2.71
TTM Avg
1.86
3Y Avg
1.80
5Y Avg
2.82
Market Cap
$89.78M
Quick Ratio (Acid-Test)
23.40
TTM Avg
7.13
3Y Avg
4.61
5Y Avg
6.59
Market Cap
$89.44M
Quick Ratio (Acid-Test)
1.00
TTM Avg
1.24
3Y Avg
1.67
5Y Avg
2.90
Market Cap
$92.69M
Quick Ratio (Acid-Test)
1.12
TTM Avg
0.72
3Y Avg
0.57
5Y Avg
0.57
Market Cap
$87.96M
Quick Ratio (Acid-Test)
1.01
TTM Avg
1.14
3Y Avg
1.20
5Y Avg
1.25
Market Cap
$87.85M
Quick Ratio (Acid-Test)
1.98
TTM Avg
0.61
3Y Avg
1.40
5Y Avg
2.59
Market Cap
$87.27M
Quick Ratio (Acid-Test)
4.50
TTM Avg
8.19
3Y Avg
12.95
5Y Avg
15.06
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Rallybio Corporation (RLYB) | $90.64M | 27.26 | 15.88 | 12.44 | 16.64 |
| Biomea Fusion, Inc. (BMEA)vs › | $90.37M | 3.47 | 4.19 | 5.60 | 16.48 |
| ImmuCell Corporation (ICCC)vs › | $90.20M | 2.71 | 1.86 | 1.80 | 2.82 |
| Equillium, Inc. (EQ)vs › | $89.78M | 23.40 | 7.13 | 4.61 | 6.59 |
| electroCore, Inc. (ECOR)vs › | $89.44M | 1.00 | 1.24 | 1.67 | 2.90 |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $92.69M | 1.12 | 0.72 | 0.57 | 0.57 |
| CareCloud, Inc. (CCLD)vs › | $87.96M | 1.01 | 1.14 | 1.20 | 1.25 |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $87.85M | 1.98 | 0.61 | 1.40 | 2.59 |
| Neumora Therapeutics, Inc. Common Stock (NMRA)vs › | $87.27M | 4.50 | 8.19 | 12.95 | 15.06 |
| Milestone Pharmaceuticals Inc. (MIST)vs › | $95.14M | 7.92 | 8.53 | 9.72 | 13.43 |
Quick Ratio
27.26
Excludes inventory
Current Ratio
27.26
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 27.26 |
| 2026-03-31 | 12.92 |
| 2025-12-31 | 14.50 |
| 2025-09-30 | 14.74 |
| 2025-06-30 | 9.98 |
| 2025-03-31 | 14.68 |
| 2024-12-31 | 10.87 |
| 2024-09-30 | 9.55 |
| 2024-06-30 | 7.52 |
| 2024-03-31 | 9.77 |
| 2023-12-31 | 12.39 |
| 2023-09-30 | 14.08 |
| 2023-06-30 | 18.23 |
| 2023-03-31 | 23.72 |
| 2022-12-31 | 16.71 |
| 2022-09-30 | 12.61 |
| 2022-06-30 | 21.20 |
| 2022-03-31 | 28.93 |
| 2021-12-31 | 27.61 |
| 2021-09-30 | 26.20 |
| 2021-06-30 | 15.99 |
| 2021-03-31 | 21.17 |
| 2020-12-31 | 24.18 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
